Q4 2024 Management View CEO Ken Moelis emphasized the company’s strong year-over-year performance across all products and sectors, with technology emerging as the largest revenue contributor in 2024.
Unlike the majority of ASX 200 income stocks, ResMed pays dividends every quarter. The post Looking to bag the record high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback